Northwest Biothrputcs Inc (NWBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,123 | -529,821 | -249,522 | -55,426 | 2,626 |
| Depreciation Amortization | 11,105 | 3,100 | 2,273 | 1,089 | 437 |
| Accounts payable and accrued liabilities | 876 | 2,133 | 986 | N/A | 1,208 |
| Other Working Capital | -2,389 | -35 | 2,352 | 2,440 | 1,246 |
| Other Operating Activity | -18,717 | 492,530 | 222,021 | 38,029 | -13,056 |
| Operating Cash Flow | $-13,248 | $-32,093 | $-21,890 | $-13,868 | $-7,539 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -264 | -6,610 | -3,548 | -1,306 | -62 |
| Net Acquisitions | N/A | -1,532 | -1,560 | N/A | N/A |
| Investing Cash Flow | $-264 | $-8,142 | $-5,108 | $-1,306 | $-62 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 13,987 | 12,062 | 6,061 | 1,240 |
| Debt Repayment | N/A | -468 | -153 | -1,427 | -64 |
| Common Stock Issued | 761 | 40,729 | 26,523 | 15,564 | 5,671 |
| Other Financing Activity | 0 | -1,552 | -1,556 | 0 | 178 |
| Financing Cash Flow | $10,761 | $52,696 | $36,876 | $20,198 | $7,025 |
| Exchange Rate Effect | 236 | -2,850 | -1,000 | 559 | 968 |
| Beginning Cash Position | 9,983 | 372 | 372 | 372 | 372 |
| End Cash Position | 7,468 | 9,983 | 9,250 | 5,955 | 764 |
| Net Cash Flow | $-2,515 | $9,611 | $8,878 | $5,583 | $392 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,248 | -32,093 | -21,890 | -13,868 | -7,539 |
| Capital Expenditure | -264 | -6,610 | -3,548 | -1,306 | -62 |
| Free Cash Flow | -13,512 | -38,703 | -25,438 | -15,174 | -7,601 |